Quest Diagnostics Q1 Revenues Grow 1 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics reported Thursday that its first quarter revenues grew around 1 percent from the previous year and beat analysts' consensus estimate.

For the three months ended March 31, Quest reported $1.86 billion in revenues compared to $1.84 billion for the first quarter in 2015 and exceeding Wall Street's expectation of $1.82 billion.

On an equivalent basis, excluding Q1 2015 revenues from the firm's clinical trials testing business that is now part of the Q2 Solutions joint venture, revenue growth was nearly 4 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Dec
06
Sponsored by
Natera

This webinar will discuss a partnership model for noninvasive prenatal testing that enabled LifeLabs Genetics, a genetic testing lab based in Toronto, Ontario, to implement NIPT in house.